Deva Holding AS (IST:DEVA) ROCE % : 14.67% (As of Sep. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Deva Holding AS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Deva Holding AS's annualized ROCE % for the quarter that ended in Sep. 2024 was 14.67%.

Deva Holding AS ROCE % Historical Data

The historical data trend for Deva Holding AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deva Holding AS ROCE % Chart

Deva Holding AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

31.74

43.23

49.97

27.82

23.78

Deva Holding AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															8.09	23.53	16.95	17.31	14.67

Deva Holding AS ROCE % Calculation

Deva Holding AS's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	3496.971	/	( ( (20535.799 - 6650.554)	+	(22443.973 - 6916.161) )	/ 2 )
	=	3496.971	/	( (13885.245	+	15527.812)	/ 2 )
	=	3496.971	/	14706.5285
	=	23.78 %

Deva Holding AS's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	2940.248	/	( ( (26786.696 - 7717.822)	+	(28913.804 - 7900.35) )	/ 2 )
	=	2940.248	/	( ( 19068.874	+	21013.454 )	/ 2 )
	=	2940.248	/	20041.164
	=	14.67 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Deva Holding AS (IST:DEVA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Deva Holding AS ROCE % Related Terms

Thank you for viewing the detailed overview of Deva Holding AS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Deva Holding AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deva Holding AS (IST:DEVA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Halkali Merkez Mahallesi, Basin Ekspres Caddesi No. 1, Kucukcekmece, Istanbul, TUR

Website

http://www.deva.com.tr

Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.

Deva Holding AS Headlines

No Headlines